Eton Pharmaceuticals, Inc. ETON Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s long-term debt?
- Eton Pharmaceuticals, Inc. (ETON) reported long-term debt of $18.94M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s long-term debt changed year-over-year?
- Eton Pharmaceuticals, Inc.'s long-term debt decreased by 36.9% year-over-year, from $29.99M to $18.94M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s long-term debt has grown at a 27.2% compound annual growth rate (CAGR), from $6.53M to $21.77M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.